The U.S. Food and Drug Administration has completed a safety review of the heart drug dronedarone trade name Multaq. The results showed an increased risk of cardiovascular issues including death with patients in permanent atrial fibrillation. The FDA is recommending a new warning label on the prescription medication to indicate the heightened risk.
Commentary
Atrial fibrillation is a cardiac arrhythmia (or abnormal heartbeat) developed in the upper two chambers of the heart. Some who suffer from an irregular heartbeat actually do not experience symptoms (other than the skipping beat) while others need medication for the discomfort they endure. My readers who fall into the latter category should be cautious and potentially consult their doctor if they are currently taking Multaq. The FDA advises if atrial fibrillation (AF) is permanent in other words chronic irregular heartbeats stop use.
Texas Drug Injury Attorney Michael Grossman
*We appreciate your feedback and welcome anyone to comment on our blog entries, however all visitor blog comments must be approved by the site moderator prior to showing live on the site. By submitting a blog comment you acknowledge that your post may appear live on the site for any visitors to see, pending moderator approval. The operators of this site are not responsible for the accuracy or content of the comments made by site visitors. By submitting a comment, blog post, or email to this site you acknowledge that you may receive a response with regard to your questions or concerns. If you contact Grossman Law Offices using this online form, your message will not create an attorney-client relationship and will not necessarily be treated as privileged or confidential! You should not send sensitive or confidential information via the Internet. Since the Internet is not necessarily a secure environment, it is not possible to ensure that your message sent via the Internet might be kept secure and confidential. When you fill out a contact or comment form, send us an email directly, initiate a chat session or call us, you acknowledge we may use your contact information to communicate with you in the future for marketing purposes, but such marketing will always be done consistent with the advertising ethics rules established by the State Bar of Texas and you will have the option to opt out of future communications.